| Patents for C07H 15 - Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals (17,975) |
|---|
| 03/27/2003 | US20030060428 Bicyclo (3.2.1)octane in a double ring system having a basic chemical skeletal of a kaurene structure that responds only at elevated plasma glucose concentrations |
| 03/27/2003 | US20030059826 Soluble combinatorial library for use as tool in drug discovery |
| 03/27/2003 | CA2460244A1 Simplified sarcodictyn derivatives as anti-tumor agents |
| 03/27/2003 | CA2460151A1 Cytokine receptor |
| 03/26/2003 | EP1042339B1 Carbohydrates, useful in solid delivery systems |
| 03/26/2003 | EP0806941B1 Low rigidity liposomal antibacterial composition |
| 03/26/2003 | CN1405127A Nitrogenous group conversion method |
| 03/26/2003 | CN1103933C Soft high oxygen permeability ophthalmic lens |
| 03/26/2003 | CN1103780C Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents |
| 03/25/2003 | US6538021 Method for producing luteolin and luteolin derivatives |
| 03/25/2003 | CA2201723C Colchicine derivatives and the therapeutical use thereof |
| 03/20/2003 | WO2003022860A1 Synthetic heparin pentasaccharides |
| 03/20/2003 | WO2003004466A3 Dye-sulfenates for dual phototherapy |
| 03/20/2003 | US20030055242 Process for the production of perbenzylated 1-O-glycosides |
| 03/20/2003 | US20030055235 Genetically engineered transferase for use as tool in genetic engineering |
| 03/20/2003 | US20030054508 Substantially pure glycopeptide antibotics AC-98-1; AC-98-2; AC-98-3; AC-98-4 AND AC-98-5 |
| 03/20/2003 | US20030054052 Triterpene compositions and methods for use thereof |
| 03/20/2003 | CA2806723A1 Synthetic heparin pentasaccharides |
| 03/20/2003 | CA2806604A1 Synthetic heparin pentasaccharides |
| 03/20/2003 | CA2806561A1 Synthetic heparin pentasaccharides |
| 03/19/2003 | EP1293248A1 Novel calixarene based dispersible colloidal system in the form of nanoparticles |
| 03/19/2003 | EP1293214A2 LTB4 antagonists and radiopharmaceuticals for imaging infection and inflammation |
| 03/19/2003 | EP1292320A2 Extracts from spermatophyte plants with immunomodulating activity |
| 03/19/2003 | EP0871490B1 Branched hydrazone linkers |
| 03/19/2003 | CN1404484A Pluraflavins and derivatives thereof, process for their preparation and use thereof |
| 03/19/2003 | CN1403467A Synthesis of rhodiola glycoside compound |
| 03/19/2003 | CN1103368C Process for producing anhydrous and non-dust granular sugar surfactant |
| 03/18/2003 | US6534637 Synthesis of chlorophenol red glucuronic acid |
| 03/18/2003 | US6534481 Antithrombin III binding domain consisting of a concatenation of five monosaccharides supporting a total of two carboxylic acid functions and at least four sulpho groups, said domain being directly bound at the non-reducing end by a thrombin |
| 03/18/2003 | US6534041 Acid-labile and enzymatically divisible dye compounds for diagnosis with near infrared light and for therapy |
| 03/18/2003 | CA2067194C Cell-free synthesis and isolation of novel genes and polypeptides |
| 03/13/2003 | WO2003020736A1 Crystaline clindamycin free base |
| 03/13/2003 | WO2002072593A3 Alkylated c-sugars and uses thereof |
| 03/13/2003 | WO2002057281A3 Aminoglycosides as antibiotics |
| 03/13/2003 | WO2001097848A3 Vitronectin receptor antagonist pharmaceuticals |
| 03/13/2003 | US20030049721 Glycoconjugates and methods |
| 03/13/2003 | CA2458644A1 Crystaline clindamycin free base |
| 03/12/2003 | EP1289944A2 Thioketals and thioethers for inhibiting the expression of vcam-1 |
| 03/12/2003 | EP0970098B1 Anthracycline glycosides |
| 03/12/2003 | EP0758243B1 BINDING OF E-SELECTIN, P-SELECTIN OR L-SELECTIN TO SIALYL-LEWISx OR SIALYL-LEWISa |
| 03/12/2003 | EP0686160A4 Solution and solid-phase formation of glycosidic linkages |
| 03/12/2003 | EP0580760B1 Antibodies of totipotent hematopoietic stem cell receptors flk-1 |
| 03/12/2003 | CN1401654A 3,4'-5-trihydroxystlbenes compounds with functions of reducing pulmonary artery high pressure and improving respiration function |
| 03/11/2003 | US6531582 2-O-(9z,12z-octadecadienoyl)-3-O-[α-D-galactopyranosyl-(1″-6′)-O-α-D-galactopyranosyl]glycerol and pharmaceutical composition containing the same |
| 03/11/2003 | US6531454 Glycosylated polyamines and methods of use therefor |
| 03/11/2003 | US6531453 Activating human NKT cell by culturing in vitro mononuclear cell fraction comprising human NKT cell in presence of specified compound or salt or solvate thereof |
| 03/06/2003 | WO2003018602A1 Ferrocene mannose derivatives activating the killing of intracellularly localised microorganisms |
| 03/06/2003 | WO2003018535A2 Novel aminobenzoephenones |
| 03/06/2003 | WO2003017949A2 Novel synthetic ganglioside derivatives and compositions thereof |
| 03/06/2003 | WO2002083066A3 Amino acid complexes of c-aryl glucosides for treatment of diabetes and method |
| 03/06/2003 | WO2002051779A3 Method for producing alcohols by hydrogenating carbonyl compounds |
| 03/06/2003 | US20030045706 Method for preparing functionalised beta-(1,3)-glucan derivatives |
| 03/06/2003 | US20030045553 Peroxisome proliferator-activated receptor agonists (PPAR) for increasing insulin sensitivity in treatment of diabetes and Syndrome X |
| 03/06/2003 | US20030045528 Antibacterial and antiprotozoal agents |
| 03/06/2003 | US20030044452 Composition for topical administration |
| 03/06/2003 | CA2457794A1 Novel synthetic ganglioside derivatives and compositions thereof |
| 03/05/2003 | EP1287011A1 Hygromycin a derivatives for the treatment of bacterial and protozoal infections |
| 03/05/2003 | CN1400976A Process for preparing indolopyrrolocarbazole derivatives, intermediates therefor, and preparation process of the intermediates |
| 03/05/2003 | CN1400975A 嘌呤衍生物 Purine derivatives |
| 03/05/2003 | CN1400216A Method for extracting ganglioside from animal tissue |
| 03/04/2003 | US6528494 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives |
| 03/04/2003 | US6528491 3'-n-Propyl-4'-(2-(3-hydroxyphenoxy)-ethoxy)-1,1'-biphenyl-4 -carboximidamide-O-beta-D-glucuronide for example; treating arthritis, asthma, psoriasis, gastrointestinal disorders, autoimmune diseases, malignant neoplasia |
| 02/27/2003 | WO2003016469A2 Chemo-enzymatic synthesis of sialylated oligosaccharides |
| 02/27/2003 | WO2003016326A1 Novel glycolipid and remedial agent for autoimmune disease containing the same as active ingredient |
| 02/27/2003 | WO2003016325A1 Association compound of trehalose or maltitol with metal ion compound |
| 02/27/2003 | WO2003004098A8 Composition for topical administration comprising an interleukin-2 inhibitor and an antimicrobial agent |
| 02/27/2003 | WO2002078597A3 Oral absorbed drugs |
| 02/27/2003 | WO2002064605A3 Synthesis of chlorophenol red glucoronic acid |
| 02/27/2003 | US20030039705 Triterpene compositions and methods for use thereof |
| 02/27/2003 | CA2456725A1 Chemo-enzymatic synthesis of sialylated oligosaccharides |
| 02/26/2003 | EP1284984A1 Uridine derivatives as antibiotics |
| 02/26/2003 | EP1284740A2 Prophylactic and therapeutic treatment of infectious, autoimmune and allergic diseases with mono- and disaccharide-based compounds |
| 02/26/2003 | CN1399641A Enzymatic substrate, synthesis method and uses |
| 02/26/2003 | CN1398872A Puerarin preparing process |
| 02/26/2003 | CN1398868A Forsythigenol extracting process |
| 02/25/2003 | US6525032 Agonists of human adenosine receptors useful as anti-inflammatory agents in treatment of diseases of respiratory tract; chemical intermediates |
| 02/25/2003 | US6525028 2-deoxy-2-amino- beta -D-glucopyranose (glucosamine) glycosidically linked to a cyclic aminoalkyl (aglycon) group; presence or absence of an antigen |
| 02/25/2003 | CA2039718C Chimeric dna-rna catalytic sequences |
| 02/20/2003 | WO2003014296A2 A group of novel anti-cancer compounds with specific structure |
| 02/20/2003 | WO2003014249A1 Sugar-derived gellant for hydrogel formation |
| 02/20/2003 | WO2003014135A1 Method for purification of acarbose |
| 02/20/2003 | WO2003013529A1 Paroxetine glycyrrhizinate |
| 02/20/2003 | WO2003013502A1 Compounds which mimic the chemical and biological properties of discodermolide |
| 02/20/2003 | WO2002064556A3 Complex carbohydrate arrays and methods for the manufacture and uses thereof |
| 02/20/2003 | US20030036538 Are designed to produce both Type 1 and Type 2 phototherapeutic effect at once using dual wavelength light source that will produce singlet oxygen and free radicals at the lesion of interest. |
| 02/20/2003 | CA2456553A1 Compounds which mimic the chemical and biological properties of discodermolide |
| 02/20/2003 | CA2456144A1 A group of novel anti-cancer compounds with specific structure |
| 02/19/2003 | EP1284102A1 Syrup-containing compositions and process for producing the same |
| 02/19/2003 | EP1283884A2 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor |
| 02/19/2003 | CN1398247A Colchinol derivatives as vascular damaging agents |
| 02/19/2003 | CN1397562A Derivative of micronomycine and its preparing process and medical application |
| 02/19/2003 | CN1397541A Trijuganone and its derivative, and its preparing process and application |
| 02/13/2003 | WO2003011880A1 Glucopyrano syloxybenzyl benzene derivative, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof |
| 02/13/2003 | WO2003011879A1 Neutral glycosphingolipids and glycosyl-sphingosines and methods for isolating the same |
| 02/13/2003 | WO2002062810A3 Linkable sialyl lewis x analogs |
| 02/13/2003 | US20030032603 New fungal strain acremonium sp.mt70646(kctc 8973p) novel compounds produced by this strain and their use |
| 02/13/2003 | US20030031738 Saponin mixtures and compounds are isolated from the species Acacia victoriae; e.g., glycosides of acacic or oleanolic acid; control of cell apoptosis and cytotoxicity; antitumor, -carcinogenic, -inflammatory and -proliferative agents |
| 02/13/2003 | CA2455347A1 Neutral glycosphingolipids and glycosyl-sphingosines and methods for isolating the same |
| 02/12/2003 | EP1283044A2 Injectable ready-to-use solutions containing an antitumor anthracycline glycoside |
| 02/11/2003 | WO2002013874A2 Use of metal complexes containing perfluoroalkyl as contrast agents in mr-imaging for the representation of plaques, tumours and necroses |